Although West Nile virus (WNV) and other arthropod-borne viruses are a major public health problem, the mechanisms of antiviral immunity in mosquitoes are poorly understood. Dicer-2, responsible for the RNAi-mediated response through the C-terminal RNase-III domain, also contains an N-terminal DExD/H-box helicase domain similar to mammalian RIG-I/MDA5 which, in Drosophila, was found to be required for activation of an antiviral gene, Vago. Here we show that the Culex orthologue of Vago (CxVago) is up-regulated in response to WNV infection in a Dicer-2-dependent manner. Further, our data show that CxVago is a secreted peptide that restricts WNV infection by activation of the Jak-STAT pathway. Thus, Vago appears to function as an IFN-like antiviral cytokine in mosquitoes.
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innate immunity | insect cytokine F laviviruses such as West Nile virus (WNV), transmitted by mosquitoes, are a major risk to human and animal health worldwide. More than one third of the world's population is at risk for flavivirus infection, and their geographical distribution is expanding as a result of increased travel and trade and global climate change (1) . WNV, first isolated in Uganda, is now endemic to parts of Africa, Europe, the Middle East, Asia, and the Americas (2) . Currently, no specific therapy or vaccine has been approved for use against WNV infection in humans. Although most research to date has focused on the human response to WNV infection, some recent studies have identified insect immune pathways that may play a role in restricting viral replication in mosquitoes (3) . Insects and other invertebrates are believed to lack key components of vertebrate adaptive and innate immune systems such as antibodies, MHC receptors, and various cytokines, including interferons (IFNs) (3) . However, the evolutionarily conserved Jak-STAT pathway, which signals the mammalian IFN response, is induced by viral infection in insects, and depletion of components of the pathway results in increased susceptibility to infection (4, 5) . In Drosophila Schneider 2 cells, expression of virus-inducible gene vir-1 in response to Drosophila C virus (DCV) infection has been shown to be under the control of a STAT-binding site in the promoter element, and vir-1 induction has been shown to be substantially reduced in hopscotchdeficient flies lacking the only known Janus kinase (4). However, overexpression or knockdown of vir-1 had no effect on resistance to DCV infection, and its function is presently unknown (4) .
Another important aspect of the insect antiviral response is the RNAi pathway through which viral dsRNA is processed by the carboxyl-terminal RNase-III domain of Dicer-2 (6) (7) (8) . A recent study in Drosophila has shown that the amino terminal DExD/H-box helicase domain of Dicer-2, which is similar to the mammalian dsRNA-sensing RIG-I/MDA5 helicase, is responsible for RNAiindependent activation of a novel antiviral gene, vago (9) . Identified in the microarray screen, vago mutant flies showed increased viral load in fat bodies. Drosophila vago encodes an 18-kDa polypeptide (DmVago) containing a single von Willebrand factor type C (VWC) domain, featuring eight conserved cysteine residues (9) . Found only in arthropods, proteins containing a single VWC domain respond to environmental changes such as bacterial infections and nutritional status (10, 11) . However, the mode of antiviral action of Vago is not known, and the significance of this Dicer-2-dependent pathway in a medically relevant infection model has not been determined to our knowledge.
WNV is generally transmitted in a bird-mosquito cycle, with occasional infections of humans and horses, which are considered dead-end hosts. Many species of mosquitoes have been shown to host WNV infection, although most isolations have been from culicine mosquitoes (12) . Here we use a WNV-Culex cell infection model to study the function of vago. We show that the Culex orthologue of DmVago is a secreted peptide that is up-regulated in response to WNV infection in a Dicer-2-dependent manner. We also demonstrate that, like mammalian IFNs, secreted Vago restricts WNV infection in Culex cells by activating the Jak-STAT pathway and up-regulates expression of the STAT-dependent virus-inducible gene vir-1. Vago, therefore, appears to function as a cytokine that acts in a manner that is similar to mammalian interferons.
Results
Mosquito Orthologues of Drosophila Vago. As Culex mosquitoes are known vectors for transmission of WNV, a cell line derived from Culex quinquefasciatus (Hsu) was used to determine the significance of Vago activation in the mosquito antiviral response (13) . By using VectorBase (http://www.vectorbase.org) (14) , salivary cysteine-rich secreted peptide (XP_001842264) was identified as an orthologue of DmVago in the Cx quinquefasciatus genome (Fig. 1A) . The 113-aa peptide showed ∼30% identity to DmVago at the amino acid level, with eight conserved cysteine residues forming a VWC domain. Orthologous proteins in Aedes and Anopheles mosquito genomes were also identified. Phylogenetic analysis of Vago-related genes indicated that the selected Cx quinquefasciatus peptide and the Ae aegyptii orthologue XP_001658930 were most closely related to DmVago (SI Appendix, Fig. S1A ). By using antibody prepared against Aedes Vago, CxVago was detected in adult Culex pipiens f. molestus mosquitoes by Western blotting, with expression levels higher in female than male mosquitoes (SI Appendix, Fig. S1B ). (Fig. 1B) . Similar results were observed following WNV infection of Culex tarsalis (Chao-Ball) cells (SI Appendix, Fig. S2A ). Western blot analysis also showed an increase in Vago protein levels in a time-dependent manner (Fig. 1C) . UV-inactivated WNV failed to induce CxVago mRNA expression, indicating a requirement of replicating virus for activation of Vago (Fig.  1B) . The induction of Vago expression was also tested following microinjection of female Culex pipiens f. molestus mosquitoes with 1.0 × 10 3 pfu of WNV (Kunjin strain). CxVago expression, as assayed by RT-qPCR, was induced 3.5 fold by 24 hpi and the levels returned to baseline by 8 d postinfection (Fig. 1F) . WNV infection and virus replication were confirmed by plaque assay with a mean recovery of 1.37 × 10 6 pfu/mosquito at 8 d. As an earlier report (9) had shown that DmVago mRNA was induced after infection by Dicer-2 activation, Hsu cells were transfected with CxDicer-2 dsRNA to silence the gene. Effective silencing of Dicer-2 mRNA and the effect of WNV infection on CxVago mRNA expression in Dicer-2-silenced cells were assessed by using RT-qPCR. The results showed more than fivefold decrease in Dicer-2 mRNA levels, indicating effective silencing (Fig.  1D ). There was significantly less increase in CxVago mRNA levels after WNV infection in Dicer-2-silenced cells compared with cells transfected with GFP dsRNA (Fig. 1E ), indicating that Dicer-2 is required for WNV-induced up-regulation of CxVago. We also confirmed that the RNAi pathway was not directly involved in Vago induction by demonstrating that it was not affected by R2D2 knockdown (SI Appendix, Fig. S3B and Fig. S8 ).
CxVago Inhibits WNV Infection in Mosquito Cells. Previous studies had shown that ΔVago-mutant Drosophila developed higher viral loads in fat bodies compared with WT flies (9). To determine whether CxVago has antiviral action, Hsu cells were transfected with a plasmid expressing V5-tagged CxVago and infected with WNV (MOI of 5) at 24 h posttransfection. The cells and supernatant medium were harvested at 48 hpi. Western blot performed with anti-V5 antibody showed overexpression of CxVago ( Fig.  2A) , and RT-qPCR with WNV NS1-specific primers showed decreased levels of WNV NS1 gene in cells at 48 and 72 hpi (Fig.  2B) , indicating decreased viral replication in Vago-overexpressing cells. Plaque assays (Fig. 2C) showed ∼40-fold decrease in viral titer at 72 hpi in the supernatant medium from cells overexpressing Vago (6.4 × 10 2 pfu/mL) compared with those transfected with the empty vector (2.5 × 10 4 pfu/mL). To determine the effect of Vago knockdown on viral titer, Hsu cells transfected with the CxVago dsRNA or GFP dsRNA (nonspecific control) were infected with WNV. The cells and the supernatant medium were harvested at 48 hpi. RT-qPCR was performed using Vago-specific and NS1-specific primers, and Western blot was performed with anti-Vago antibody. The results showed significant decreases in Vago protein (Fig. 3A) and mRNA ( Fig. 3B ) levels in cells transfected with Vago dsRNA and increased levels of NS1 RNA (Fig. 3C ). Plaque assays performed on the supernatant medium collected from the cells at 48 hpi ( (Fig. 4A) , and there was a significant decrease in Vago secretion from WNVinfected cells following Dicer-2 knockdown compared with control cells treated with GFP dsRNA (Fig. 4A ). This indicates that Dicer-2-mediated induction of Vago leads to its secretion from Culex cells.
Secreted CxVago Has Antiviral Activity. Experiments were conducted to determine the antiviral action of secreted Vago. Supernatant medium was collected from Hsu cells overexpressing CxVago (without V5-tag) at 48 h posttransfection and was added to fresh cultures of Hsu cells infected simultaneously with WNV (MOI of 5). The supernatant medium was collected at 48 hpi, and viral titers were measured by plaque assay. The results (Fig.  4B) showed a 30-fold reduction in viral titers (1.1 × 10 2 pfu/mL) in supernatants from cells treated with CxVago compared with the medium from untreated cells (3.5 × 10 3 pfu/mL). Treatment with medium from GFP-transfected cells showed viral titers similar to control cells (3.2 × 10 3 pfu/mL). The results indicate that the secreted form of Vago restricts WNV replication in Culex cells. To further confirm the antiviral action of secreted Vago, Hsu cells were transfected with plasmid containing CxVago, in which the predicted signal peptide cleavage site was mutated (Ala20 > Thr), abolishing Vago secretion (SI Appendix, Fig. S5C ). The supernatant medium was collected at 48 h posttransfection and added to fresh cultures of Hsu cells infected simultaneously with WNV. Plaque assays indicated significantly higher titers in the supernatant medium from these cells compared with the medium from cells transfected with plasmid expressing WT CxVago (Fig. 4B) , confirming the antiviral action of secreted Vago.
Similar experiments were conducted to compare the effect of preinfection and postinfection treatment of Hsu cells with CxVago. Cells treated with supernatant medium containing secreted CxVago 2 h before infection or simultaneously with WNV were protected to the same extent, showing 30-and 25-fold lower viral titers, respectively, by plaque assays at 48 hpi compared with cells treated the medium control. However, cells treated with CxVago at 2 hpi showed no significant difference in viral titer compared with control cells (Fig. 4C) , indicating that CxVago is effective only in the initial stages of WNV infection. RT-qPCR assays using (Fig. 4D) . This suggests that the Jak-STAT pathway was activated by CxVago postinfection treatment but it failed to restrict WNV infection. African green monkey (Vero) cells were also treated with supernatant medium from CxVagooverexpressing cells simultaneously with WNV infection. Plaque assays showed no change in the viral titers in these cells compared with control medium-treated cells (SI Appendix, Fig. S5E ), indicating that CxVago does not affect WNV infectivity per se and that the target of CxVago is insect cell-specific. Secreted CxVago Activates the Jak-STAT Pathway to Restrict WNV Infection. Experiments were conducted to determine if the antiviral activity of secreted CxVago occurs through receptor-mediated activation of a cell signaling pathway. RT-qPCR assays were performed on Hsu cells treated with secreted CxVago using markers for Jak-STAT (vir-1) activation (4) and NF-kB (defensin-A) activation (16). Hsu cells treated for 24 h with supernatant medium containing secreted CxVago showed two-to threefold up-regulation of vir-1 expression but no significant change in defensin-A expression (Fig. 5A) . To determine whether activation of the Jak-STAT pathway is responsible for CxVago antiviral activity, Hsu cells transfected with CxSTAT2 dsRNA were infected with WNV and treated simultaneously with the supernatant medium containing secreted CxVago. RT-qPCR assays confirmed effective silencing of CxSTAT2 and no induction of the STAT marker gene (vir-1) after STAT silencing (Fig. 5C ). Plaque assays conducted at 48 hpi showed 25-to 30-fold higher viral titer in the supernatant from cells transfected with CxSTAT2 dsRNA (7.8 × 10 3 pfu/mL) compared with control dsRNA (i.e., GFP; 2.8 × 10 2 pfu/mL; Fig.  5B ), indicating that the antiviral activity of CxVago is dependent on CxSTAT2. Silencing of CxJak (DmHopscotch orthologue) also prevented activation of vir-1 and abolished antiviral activity of secreted CxVago treatment (SI Appendix, Fig. S6 ). These data indicate that CxVago activates the Jak-STAT pathway, stimulating expression of downstream genes that restrict WNV replication in mosquito cells.
In Drosophila, Jak-STAT activation occurs when the ligand "unpaired" (UPD) binds to the receptor Domeless on the cell surface (17) . To determine whether this receptor is involved in Vago-induced signaling in mosquitoes, the Culex orthologue of Drosophila Domeless (CxDome) was silenced by transfection of Hsu cells with CxDome dsRNA. After 24 h, the cells were infected with WNV and treated simultaneously with supernatant medium containing secreted CxVago. RT-qPCR assays conducted to detect expression of Dome, vir-1, and WNV NS1 as a marker of virus replication, confirmed that there was effective silencing of CxDome but that silencing had no significant effect on CxVago-induced vir-1 expression or on CxVago-induced suppression of WNV replication (Fig. 5D) . Although some leakage of CxDome-mediated signaling following knockdown cannot be excluded, the data suggest that CxVago-stimulated vir-1 expression is independent of Dome and that the antiviral response occurs via an alternative Jak receptor.
Discussion
Despite the importance of arthropods as vectors of disease, the immune response of arthropods to viral infection is poorly understood. Previous studies in Drosophila and mosquitoes have established the importance of RNAi (6) (7) (8) and demonstrated that the Toll, Imd, and Jak-STAT signaling pathways have roles in antiviral immunity (4, 5, 18, 19) . Evidence in Drosophila that dsRNA sensing by the Dicer-2 DExD/H-box helicase domain stimulates an antiviral response mediated by the cysteine-rich peptide Vago has suggested the existence of a pathway that may function similarly to the RIG-I/MDA5-activated IFN response in vertebrates. However, there has been no previous evidence in insects or other invertebrates of cytokine activity through which the innate antiviral response is communicated locally or systemically (3). Here, we have identified the Culex orthologue of DmVago and determined its mode of action during WNV infection of mosquito cells. Our data demonstrate that CxVago is a stable, secreted cytokine that stimulates an insect cell-specific antiviral response by activating the Jak-STAT pathway. We demonstrate that Vago induction in mosquitoes occurs by a Dicer-2-dependent mechanism, elaborating the significance of the previous work in Drosophila (9) , and that Vago activates expression of the Culex orthologue of the virus-inducible Drosophila gene vir-1. We also show that this antiviral response requires viable replicating WNV. Thus, although Vago displays no structural homology with mammalian IFNs, it appears to serve a similar function in mosquitoes.
In contrast to our results, Deddouche et al. (9) were unable to establish a link between DCV-stimulated Vago up-regulation and the induction of vir-1 in Drosophila. They observed that vir-1 remained fully inducible in ΔVago-mutant flies and that suppression of RNAi by the dsRNA-binding Flock House virus B2 protein decreased DCV-induced up-regulation of Vago but did not suppress vir-1 induction. Furthermore, it was argued that the fat body tissue specificity of Vago gene expression, sequence divergence among Drosophila species, and lack of conservation of the gene in other insects reinforce the view that it does not function as a circulating cytokine. However, direct functional analysis was not possible in previous studies as a result of the poor stability of expressed DmVago, and it could be argued that induction of vir-1 in the absence of a Vago response may occur by an alternative mechanism. In mammalian cells, the Jak-STAT pathway can be activated by a number of different cytokines including IFNs, ILs, and various growth factors (20, 21) . Whereas IFNs are activated by dsRNA-sensing via RIG-I/MDA5 or Toll-like receptors (e.g., TLR3) (22) , ILs are activated by ssRNA via TLR7/8 (23) . Arguably, the Jak-STAT pathway in insects may also be activated by multiple cytokines induced by various virus-specific molecular patterns. If so, vir-1 could be induced by Vago in response to viral infection but still remain fully inducible by other, yet unidentified, virus-activated cytokines in the absence of Vago expression.
Our data also demonstrate that the antiviral function of Vago is preserved in Drosophila and mosquitoes despite the absence of extensive sequence homology, and we have shown that Aedes Vago is functionally active in Culex cells. This suggests the critical structure of the receptor-binding region may be defined by a secondary structural fold stabilized by the eight conserved cysteine residues and antiparallel β-sheets of the of the VWC domain (10) . The single VWC domain (SVC) protein family appears to occur only in arthropods, including mosquitoes, flies, ticks, midges, moths, beetles, bees, scorpions, and shrimp (10, 24) . Several of the 13 SVC family members identified in Drosophila are expressed only in specific tissues, including the fat body, which regulates immune and nutritional processes, and the salivary gland, in which virus replication efficiency is a critical factor in arbovirus transmission (10) . SVC genes have also been shown to be under nutritional control, and it has been proposed that they may be induced in response to environmental stress (10, 11) . However, it is not clear at this time if antiviral activity is common function among SVC proteins and whether, like mammalian IFNs, the various isoforms may differentially regulate various aspects of the antiviral response.
Analysis of the kinetics of the antiviral activity of secreted recombinant CxVago indicated that it was effective only when delivered simultaneously or up to 2 h before WNV infection. Vago treatment at 2 hpi resulted in lower levels of vir-1 activation and failed to inhibit WNV infection. A similar effect has been observed during flavivirus infection of mammalian cells in which in IFN treatment was also far less effective in blocking viral replication and other antiviral functions when delivered 4 hpi (25) . In flaviviruses and other RNA viruses, the failure of IFN treatment postinfection has been attributed to virus-induced shut-down of host cell protein synthesis and the action of virusencoded antagonists that block Jak-STAT-mediated expression of IFN-inducible genes (26, 27) .
Further studies are required to identify the Vago receptor. Previous experiments have indicated that DCV-induced vir-1 expression is regulated by Domeless (4), encoding the only Jak-STAT receptor identified in Drosophila to date and an orthologue of mammalian class I cytokine receptors. UPD-like secreted proteins have been implicated as Domeless ligands (17, 28, 29) , but they share no detectable structural homology with Vago and in silico searches have failed to detect obvious UPD orthologues in mosquitoes or other invertebrates (30) . Furthermore, our data indicated that Domeless knockdown had no significant effect on CxVago-induced vir-1 expression or CxVago-induced suppression of WNV replication. Taken together, these observations suggest that Vago may stimulate Jak-STAT signaling and the antiviral response via an alternative, yet unidentified, receptor. The downstream STAT-activated antiviral effector genes are also unknown. Overexpression or knockdown of vir-1 has been reported to have no effect on DCV resistance in Drosophila, and its function remains unclear (4). Our studies have also indicated that overexpression of CxVir-1 in Hsu cells does not lead to reduced viral titers (SI Appendix, Fig. S7) . A large number of other genes have been reported to be up-regulated in arthropods in response to viral infection (4, 31, 32) . A recent report has shown that a cecropin-like peptide induced in mosquito salivary glands in response for Dengue virus infection has broad-spectrum antiviral and antibacterial activity, but the mechanisms of its induction and antiviral action are unknown (33) .
The existence in insects of an immune pathway that appears similar to the vertebrate IFN system, permitting cell-to-cell communication of the antiviral response, provides a complementary defensive mechanism to the systemic RNAi response, which has been shown to inhibit replication and limit virus dissemination (34, 35) . Further characterization of this antiviral pathway may assist in understanding vector competence and the dynamics of emergence of flaviviruses and other important vector-borne pathogens, and may present opportunities for the development of novel interventions for disease control.
Materials and Methods
Cell Culture and Virus Propagation. Hsu, Vero, BHK, and C6/36 cells were maintained and viruses were propagated as detailed in SI Appendix.
Mosquito Maintenance and Viral Infections. A colony of Culex pipiens f. molestus mosquitoes was maintained at 25°C and 65% humidity. Fiveday-old mosquitoes were infected and further analyzed as detailed in SI Appendix. ) and, at 48 hpi, RT-qPCR was performed by using primers specific for vir-1, WNV NS1 or CxDomeless. Fold increase was calculated and plotted vs. control (baseline). Error bars in RT-qPCR assays represent SE from three separate experiments with assays performed in triplicate (*P < 0.05, Student t test).
Plaque Assays. Viral titers were determined by plaque assay on Vero cells as detailed in SI Appendix. Plaques were counted and titers were estimated by dilution factor.
Western Blotting. Anti-Vago antibody (GenScript) was prepared in rabbits by using the C-terminal peptide CEKIKQDLTKDYPE. Anti-V5 antibody was purchased from Invitrogen. Anti-β-actin antibody was purchased from Abcam. Western blot was performed as detailed in SI Appendix.
Viral dsRNA Preparation and Transfection. Total RNA was extracted from WNVinfected Hsu cells or bluetongue virus-infected BHK cells at 48 hpi by using TRIzol (Invitrogen) according to the manufacturer's instructions. ssRNA was removed by precipitation with 2 M LiCl and centrifugation at 16,500 × g for 10 min. dsRNA in the supernatant fraction was precipitated with isopropanol and purified by using an ethanol wash. Hsu cells were transfected with the purified dsRNA or poly I:C (GE Healthcare) in Cellfectin (Invitrogen) according to the manufacturer's instructions.
Competitive ELISA for Assay of Vago. ELISA was performed for assay of secreted Vago in supernatant media. In brief, 96-well plates were coated with 5 μg/mL CxVago (C-terminal) peptide in 50 mM carbonate buffer, pH 9.6. After washing, plates were blocked for 2 h at room temperature by using BSA (1% in PBS solution). Tenfold dilutions of peptide or supernatant medium were incubated with anti-Vago antibody (1:50,000) for 2 h at 37°C. The mixture was then added to wells and incubated for 2 h at 37°C. Secondary antibody (HRP-labeled goat anti-rabbit) was added and, after similar incubation, 3,3′,5,5′-TMB liquid substrate (Sigma) was used to quantify Vago by determining absorbance at 560 nm.
Real-Time RT-qPCR. Total RNA was collected from Hsu cells and homogenized mosquitoes using the RNeasy kit (Qiagen) and RT-qPCR was performed as detailed in SI Appendix.
Overexpression and Gene Silencing. Cx quinquefasciatus Vago was cloned into pIZ-V5/His vector (Invitrogen) for overexpression in Hsu cells. For mutations in the signal peptide, a Site-Directed Mutagenesis Kit (Ambion) was used according to the manufacturer's instructions. Cloning and mutations were confirmed by direct sequencing. For gene silencing, dsRNA was prepared using a MEGAscript RNAi kit (Ambion) according to the manufacturer's instructions, with primers as shown in SI Appendix, Table S1 . Transfection of plasmids and dsRNA was performed by using Cellfectin II (Invitrogen).
Statistical Analysis. SEM was calculated and data analyzed by using the nonpaired Student t test for single mean comparisons.
